Chronic dementing conditions, genomics, and new opportunities for nursing interventions

Journal of Nursing Scholarship

Volumn 38, Issue 4, 2006, Pages 328-334

  Schutte, Debra L ^a   Holston, Ezra C ^b  

^a UNIVERSITY OF IOWA COLLEGE OF NURSING   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer disease; Dementia; Genetics; Gerontology; Parkinson disease

Indexed keywords

ALZHEIMER DISEASE; CHRONIC DISEASE; DEMENTIA; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; NURSING; PARKINSON DISEASE; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

ALZHEIMER DISEASE; CHRONIC DISEASE; DEMENTIA; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; PARKINSON DISEASE; RISK FACTORS;

EID: 33750870577     PISSN: 15276546     EISSN: 15475069     Source Type: Journal    
DOI: 10.1111/j.1547-5069.2006.00123.x     Document Type: Review

References (58)

1. Aarsland, D., Bronnick, K., Ehrt, U., De Deyn, P.P., Tekin, S., Emre, M., et al. (2006). Neuropsychiatric symptoms in patients with PD and dementia: Frequency, profile, and associated caregiver stress. Retrieved September 26, 2006, from http://jnnp.bmjjournals.com/cgi/content/abstract/jnnp.2005.083113v1
2. Abel, E., Horner, S.D., Tyler, D., & Innerarity, S.A. (2005). The impact of genetic information on policy and clinical practice. Policy, Politics, & Nursing Practice, 6(1), 5-14.
3. Almeida, O.P., Hulse, G.K., Lawrence, D., & Flicker, L. (2002). Smoking as a risk factor for Alzheimer's disease: Contrasting evidence from a systematic review of case-control studies. Addiction, 97(1), 15-28.
4. American Nurses Association. (1998). Statement on the scope and standards of genetics clinical nursing practice (Pub# 9807ST). Washington, DC: American Nurses Publishing.
5. American Psychiatric Association. (1994). DSM-IV: Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
6. Barlow-Stewart, K., Yeo, S.B., Meiser, B., Goldstein, D., & Tucker, K. (2006). Toward cultural competence in cancer genetic counseling and genetics education: Lessons learned from Chinese-Australians. Genetics in Medicine, 8(1), 24-32.
7. Bird, T.D. (2005). Alzheimer's disease overview. Retrieved December 12, 2005, from http://www.genetests.org
8. Collins, F.S., Green, E.D., Guttmacher, A.E., & Guyer, M.S. (2003). A vision for the future of genomics research. Nature, 422(6934), 835-847.
9. Cummings, J.L., & McPherson, S. (2001). Neuropsychiatric assessment of Alzheimer's disease and related dementias. Aging (Milano), 13(3), 240-246.
10. de Rijk, M.C., Tzourio, C., Breteler, M.M., Dartigues, J.F., Amaducci, L., Lopez-Pousa, S., et al. (1997). Prevalence of parkinsonism and Parkinson's disease in Europe: The EUROPARKINSON Collaborative Study. European community concerted action on the epidemiology of Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 62, 10-15.
11. Emre, M. (2004). Dementia in Parkinson's disease: Cause and treatment. Current Opinions in Neurology, 17, 399-404.
12. Evans, D.A., Bennett, D.A., Wilson, R.S., Bienias, J.L., Morris, M.C., Scherr, P.A., et al. (2003). Incidence of Alzheimer disease in a biracial urban community. Archives of Neurology, 60, 185-189.
13. Ferri, C.P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., et al. (2005). Global prevalence of dementia: A Delphi consensus study. Lancet, 366, 2112-2117.
14. Foroud, T., Uniacke, S.K., Liu, L., Pankratz, N., Rudolph, A., Halter, C., et al. (2003). Heterozygosity for a mutation in the Parkin gene leads to later onset PD. Neurology, 60, 796-801.
15. Graff-Radford, N.E., Green, R.C., Go, R.C.P., Hutton, M.L., Edeki, T., Bachman, D., et al. (2002). Association between Apolipoprotein E genotype and Alzheimer disease in African American subjects. Archives of Neurology, 59, 594-600.
16. Goate, A., Chartier-Harlin, M.C., Mullan, M., Brown, J., Crawford, F., Fidani, L., et al. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature, 349(6311), 704-706.
17. Gorell, J.M., Johnson, C.C., Rybicki, B.A., Peterson, E.L., Kortsha, X., Brown, G.G., et al. (1999). Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology, 20, 239-247.
18. Gorell, J.M., Rybicki, B.A., Johnson, C.C., & Peterson, E.L. (1999). Smoking and Parkinson's disease: A dose-response relationship. Neurology, 52, 115-119.
19. Hebert, L.E., Beckett, L.A., Scherr, P.A., & Evans, D.A. (2001). Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Disease & Associated Disorders, 15(4), 169-173.
20. Hendrie, H.C., Ogunniyi, A., Hall, K.S., Baiyewu, O., Unverzagt, F.W., Gureje, O., et al. (2001). Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria and African Americans residing in Indianapolis, Indiana. JAMA, 285(6), 739-747.
21. Holston, E.C., & Schutte, D.L. (2004). The clinical utility of genetic information in the care of people with Alzheimer's disease. MEDSURG Nursing: The Journal of Adult Health, 13(6), 415-419.
22. Hurley, A.C., Harvey, F.R., Roberts, J.S., Wilson-Chase, C., Lloyd, S., Prest, J., et al. (2005). Genetic susceptibility for Alzheimer's disease: Why did adult offspring seek testing? American Journal of Alzheimer's Disease and Other Dementias, 20(6), 374-381.
23. Ikonomovic, M.D., Uryu, K., Abrahamson, E.E., Ciallella, J.R., Trojanowski, J.Q., Lee, V.M., et al. (2004). Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Experimental Neurology, 190(1), 192-203.
24. Janevic, M.R., & Connell, C.M. (2001). Racial, ethnic, and cultural differences in the dementia caregiving experience: Recent findings. The Gerontologist, 41(3), 334-347.
25. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., et al. (1998). Mutations in the Parkin gene cause autosomal recessive juvenile Parkinsonism. Nature, 392, 605-608.
26. Kirkey, K.L., Johnson, C.C., Rybicki, B.A., Peterson, E.L., Kortsha, G.X., & Gorell, J.M. (2001). Occupational categories at risk for Parkinson's disease. American Journal of Industrial Medicine, 39, 564-571.
27. Kukull, W.A. (2001). The association between smoking and Alzheimer's disease: Effects of study design and bias. Biological Psychiatry, 49, 194-199.
28. Langston, J.W., Ballard, P., Tetrud, J.W., & Irwin, I. (1983). Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science, 219, 979-980.
29. Le, W.D., Xu, P., Jankovic, J., Jiang, H., Appel, S.H., Smith, R.G., et al. (2003). Mutations in NR4A2 associated with familial Parkinson disease. Nature Genetics, 33, 85-89.
30. Lee, P.N. (1994). Smoking and Alzheimer's disease: A review of the epidemiological evidence. Neuroepidemiology, 13(4), 131-144.
31. Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., et al. (1998). The ubiquitin pathway in Parkinson's disease. Nature, 395, 451-452.
32. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D.M., Oshima, J., Pettingell, W.H., et al. (1995). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science, 269(5226), 973-977.
33. Lieberman, A. (1998). Managing the neuropsychiatric symptoms of Parkinson's disease. Neurology, 50(Suppl. 6), S33-S48.
34. Lyketsos, C.G., Steinberg, M., Tschanz, J.T., Norton, M.C., Steffens, D.C., & Breitner, J.C.S. (2000). Mental and behavioral disturbances in dementia: Findings from the Cache County Study on memory in aging. American Journal of Psychiatry, 157(5), 708-714.
35. Magaziner, J., German, P., Zimmerman, S.I., Hebel J.R., Burton, L., Gruber-Baldini, A.L., et al. (2000). The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: Diagnosis by expert panel. The Gerontologist, 40(6), 663-672.
36. Marx, F.P., Holzmann, C., Strauss, K.M., Li, L., Eberhardt, O., Gerhardt, E., et al. (2003). Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. Human Molecular Genetics, 12, 1223-1231.
37. McGonigal-Kenney, M., & Schutte, D.L. (2006). Evidence-based protocol: Non-pharmacologic management of agitated behaviors in people with Alzheimer disease and other chronic dementing conditions. Journal of Gerontological Nursing, 32(2), 9-14.
38. Mitnitski, A.B., Graham, J.E., Mogilner, A.J., & Rockwood, K. (1999). The rate of decline in function in Alzheimer's disease and other dementias. Journals of Gerontology. Series A, Biological Sciences & Medical Sciences, 54(2), M65-M69.
39. Myers, A.J., & Goate, A.M. (2001). The genetics of late-onset Alzheimer's disease. Current Opinions in Neurology, 14(4), 433-440.
40. National Institute of Neurological Disorders and Stroke. (2004). Parkinson's disease: A research planning workshop. Retrieved on July 5, 2005, from www.ninds.nih.gov/news_and_events/proceedings/ parkinson_workshop_proceeding.htm
41. National Institute on Aging. (2003). 2001-2002 Progress report on Alzheimer's disease (NIH Publication No. 03-5333). Washington, DC: U.S. Department of Health and Human Services, Public Health Services, National Institutes of Health.
42. Pankratz, N.D., Wojcieszek, M.D., & Foroud, T. (2004). Parkinson disease overview. Retrieved July 5, 2005, from http://www.genetests.org
43. Parashos, S.A., Maraganore, D.M., O'Brien, P.C., & Rocca, W.A. (2002). Medical services utilization and prognosis in Parkinson disease: A population-based study. Mayo Clinic Proceedings, 77(9), 918-925.
44. Pericak-Vance, M.A., Bebout, J.L., Gaskell, P.C. Jr., Yamaoka, L.H., Hung, W.Y., Alberts, M.J., et al. (1991). Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage. American Journal of Human Genetics, 48(6), 1034-1050.
45. Piccini, C., Pecori, D., Campani, D., Falcini, M., Piccininni, M., Manfredi, G., et al. (1998). Alzheimer's disease: Patterns of cognitive impairment at different levels of disease severity. Journal of the Neurological Sciences, 156(1), 59-64.
46. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047.
47. Priyadarshi, J.A., Khuder, S.A., Schaub, E.A., & Shrivastava, S. (2000). A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology, 21, 435-440.
48. Racette, B.A., McGee-Minnich, L., Moerlein, S.M., Mink, J.W., Videen, T.O., & Perlmutter, J.S. (2001). Welding-related Parkinsonism: Clinical features, treatment, and pathophysiology. Neurology, 56, 8-13.
49. Rolland, J.S., & Williams, J.K. (2005). Toward a biopsychosocial model for 21st-century genetics. Family Process, 44(1), 3-24.
50. Schutte, D.L. (2004). The evolving role of genomics in shaping care for people with dementia. Nursing Clinics of North America, 39, 581-592.
51. Schutte, D.L., Maas, M., & Buckwalter, K.C. (2003). A LRPAP1 intronic insertion/deletion polymorphism and phenotypic variability in Alzheimer disease. Research & Theory for Nursing Practice: An International Journal, 17(4), 301-319.
52. Schutte, D.L., McCarthy, A.M., Floria-Santos, M., Hanrahan, K., Murray, J.C., & Kleiber, C. (2006). Integrating molecular genetics analyses into clinical research. Biological Research for Nursing, 8(1), 67-77.
53. Skirton, H., Frazier, L.Q., Calvin, A.O., & Cohen, M.Z. (2006). A legacy for the children - attitudes of older adults in the United Kingdom to genetic testing. Journal of Clinical Nursing, 15, 565-573.
54. St. George-Hyslop, P., Haines, J., Rogaev, E., Mortilla, M., Vaula, G., Pericak-Vance, M., et al. (1992). Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nature Genetics, 2(4), 330-334.
55. Valente, E.M., Brancati, F., Ferraris, A., Graham, E.A., Davis, M.B., Breteler, M.M., et al. (2002). PARK6-linked parkinsonism occurs in several European families. Annals of Neurology, 51, 14-18.
56. Van Den Eeden, S.K., Tanner, C.M., Bernstein, A.L., Fross, R.D., Leimpeter, A., Bloch, D.A., et al. (2003). Incidence of Parkinson's disease: Variation by age, gender, and race/ethnicity. American Journal of Epidemiology, 157, 1015-1022.
57. van Duijn, C.M., Dekker, M.C., Bonifati, V., Galjaard, R.J., Houwing-Duistermaat, J.J., Snijders, P.J., et al. (2001). Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. American Journal of Human Genetics, 69, 629-634.
58. Wimo, A., Winblad, B., Aguero-Torres, H., & von Strauss, E. (2003). The magnitude of dementia occurrence in the world. Alzheimer Disease & Associated Disorders, 17(2), 63-67.